+1 347 708 0418
Postmenopausal Vaginal Atrophy (PVA) Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Postmenopausal Vaginal Atrophy (PVA) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Drugs Treatment
Other Treatments
Segment by Application
Hospital
Clinic
Others
By Company
Endoceutics
Accord Healthcare
Pfizer
Novo Nordisk
Teva Pharmaceuticals
Shionogi & Co
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Drugs Treatment
1.2.3 Other Treatments
1.3 Market by Application
1.3.1 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Perspective (2017-2028)
2.2 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Growth Trends by Region
2.2.1 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Dynamics
2.3.1 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Industry Trends
2.3.2 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Drivers
2.3.3 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Challenges
2.3.4 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Postmenopausal Vaginal Atrophy (PVA) Therapeutics Players by Revenue
3.1.1 Global Top Postmenopausal Vaginal Atrophy (PVA) Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue
3.4 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Concentration Ratio
3.4.1 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue in 2021
3.5 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Key Players Head office and Area Served
3.6 Key Players Postmenopausal Vaginal Atrophy (PVA) Therapeutics Product Solution and Service
3.7 Date of Enter into Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Breakdown Data by Type
4.1 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Forecasted Market Size by Type (2023-2028)
5 Postmenopausal Vaginal Atrophy (PVA) Therapeutics Breakdown Data by Application
5.1 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size (2017-2028)
6.2 North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type
6.2.1 North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Type (2017-2028)
6.3 North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application
6.3.1 North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Application (2017-2028)
6.4 North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Country
6.4.1 North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size (2017-2028)
7.2 Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type
7.2.1 Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Type (2017-2028)
7.3 Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application
7.3.1 Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Application (2017-2028)
7.4 Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Country
7.4.1 Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type
8.2.1 Asia-Pacific Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application
8.3.1 Asia-Pacific Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Region
8.4.1 Asia-Pacific Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size (2017-2028)
9.2 Latin America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type
9.2.1 Latin America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application
9.3.1 Latin America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Country
9.4.1 Latin America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type
10.2.1 Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application
10.3.1 Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Country
10.4.1 Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Endoceutics
11.1.1 Endoceutics Company Details
11.1.2 Endoceutics Business Overview
11.1.3 Endoceutics Postmenopausal Vaginal Atrophy (PVA) Therapeutics Introduction
11.1.4 Endoceutics Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2017-2022)
11.1.5 Endoceutics Recent Developments
11.2 Accord Healthcare
11.2.1 Accord Healthcare Company Details
11.2.2 Accord Healthcare Business Overview
11.2.3 Accord Healthcare Postmenopausal Vaginal Atrophy (PVA) Therapeutics Introduction
11.2.4 Accord Healthcare Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2017-2022)
11.2.5 Accord Healthcare Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Postmenopausal Vaginal Atrophy (PVA) Therapeutics Introduction
11.3.4 Pfizer Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2017-2022)
11.3.5 Pfizer Recent Developments
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Details
11.4.2 Novo Nordisk Business Overview
11.4.3 Novo Nordisk Postmenopausal Vaginal Atrophy (PVA) Therapeutics Introduction
11.4.4 Novo Nordisk Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2017-2022)
11.4.5 Novo Nordisk Recent Developments
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Details
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Therapeutics Introduction
11.5.4 Teva Pharmaceuticals Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2017-2022)
11.5.5 Teva Pharmaceuticals Recent Developments
11.6 Shionogi & Co
11.6.1 Shionogi & Co Company Details
11.6.2 Shionogi & Co Business Overview
11.6.3 Shionogi & Co Postmenopausal Vaginal Atrophy (PVA) Therapeutics Introduction
11.6.4 Shionogi & Co Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2017-2022)
11.6.5 Shionogi & Co Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Drugs Treatment
Table 3. Key Players of Other Treatments
Table 4. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Region (2017-2022)
Table 8. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Region (2023-2028)
Table 10. Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Trends
Table 11. Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Drivers
Table 12. Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Challenges
Table 13. Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Restraints
Table 14. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Share by Players (2017-2022)
Table 16. Global Top Postmenopausal Vaginal Atrophy (PVA) Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics as of 2021)
Table 17. Ranking of Global Top Postmenopausal Vaginal Atrophy (PVA) Therapeutics Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Postmenopausal Vaginal Atrophy (PVA) Therapeutics Product Solution and Service
Table 21. Date of Enter into Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Market Share by Type (2017-2022)
Table 25. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Market Share by Type (2023-2028)
Table 27. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Share by Application (2017-2022)
Table 29. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue Share by Application (2023-2028)
Table 31. North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 61. Endoceutics Company Details
Table 62. Endoceutics Business Overview
Table 63. Endoceutics Postmenopausal Vaginal Atrophy (PVA) Therapeutics Product
Table 64. Endoceutics Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2017-2022) & (US$ Million)
Table 65. Endoceutics Recent Developments
Table 66. Accord Healthcare Company Details
Table 67. Accord Healthcare Business Overview
Table 68. Accord Healthcare Postmenopausal Vaginal Atrophy (PVA) Therapeutics Product
Table 69. Accord Healthcare Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2017-2022) & (US$ Million)
Table 70. Accord Healthcare Recent Developments
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Postmenopausal Vaginal Atrophy (PVA) Therapeutics Product
Table 74. Pfizer Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2017-2022) & (US$ Million)
Table 75. Pfizer Recent Developments
Table 76. Novo Nordisk Company Details
Table 77. Novo Nordisk Business Overview
Table 78. Novo Nordisk Postmenopausal Vaginal Atrophy (PVA) Therapeutics Product
Table 79. Novo Nordisk Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2017-2022) & (US$ Million)
Table 80. Novo Nordisk Recent Developments
Table 81. Teva Pharmaceuticals Company Details
Table 82. Teva Pharmaceuticals Business Overview
Table 83. Teva Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Therapeutics Product
Table 84. Teva Pharmaceuticals Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2017-2022) & (US$ Million)
Table 85. Teva Pharmaceuticals Recent Developments
Table 86. Shionogi & Co Company Details
Table 87. Shionogi & Co Business Overview
Table 88. Shionogi & Co Postmenopausal Vaginal Atrophy (PVA) Therapeutics Product
Table 89. Shionogi & Co Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2017-2022) & (US$ Million)
Table 90. Shionogi & Co Recent Developments
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Drugs Treatment Features
Figure 3. Other Treatments Features
Figure 4. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Application: 2021 VS 2028
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Postmenopausal Vaginal Atrophy (PVA) Therapeutics Report Years Considered
Figure 9. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Region: 2021 VS 2028
Figure 12. Global Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Share by Players in 2021
Figure 13. Global Top Postmenopausal Vaginal Atrophy (PVA) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postmenopausal Vaginal Atrophy (PVA) Therapeutics as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Postmenopausal Vaginal Atrophy (PVA) Therapeutics Revenue in 2021
Figure 15. North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Market Share by Type (2017-2028)
Figure 17. North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Market Share by Application (2017-2028)
Figure 18. North America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Share by Country (2017-2028)
Figure 19. United States Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Market Share by Type (2017-2028)
Figure 23. Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Market Share by Application (2017-2028)
Figure 24. Europe Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Share by Country (2017-2028)
Figure 25. Germany Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Share by Region (2017-2028)
Figure 35. China Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Share by Country (2017-2028)
Figure 45. Mexico Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size Share by Country (2017-2028)
Figure 51. Turkey Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Postmenopausal Vaginal Atrophy (PVA) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Endoceutics Revenue Growth Rate in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2017-2022)
Figure 55. Accord Healthcare Revenue Growth Rate in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2017-2022)
Figure 56. Pfizer Revenue Growth Rate in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2017-2022)
Figure 57. Novo Nordisk Revenue Growth Rate in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2017-2022)
Figure 58. Teva Pharmaceuticals Revenue Growth Rate in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2017-2022)
Figure 59. Shionogi & Co Revenue Growth Rate in Postmenopausal Vaginal Atrophy (PVA) Therapeutics Business (2017-2022)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Buy
